Fuji Pharma. 

€9.70
0
+€0.10+1.04% Friday 19:46

Statistics

Day High
9.7
Day Low
9.55
52W High
9.7
52W Low
9.55
Volume
-
Avg. Volume
-
Mkt Cap
257.45M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q2 2026
Next
0.23
0.56
0.9
1.23
Expected EPS
N/A
Actual EPS
N/A

Financials

2.4%Profit Margin
Profitable
2021
2022
2023
2024
2025
2026
161.67MRevenue
3.88MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow FUP.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Astellas Pharma
4503.TSE
Mkt Cap3.68T
Astellas Pharma Inc. is a direct competitor, focusing on pharmaceuticals, including women's health, similar to Fuji Pharma's market focus.
Sumitomo Pharma.
4506.TSE
Mkt Cap419.94B
Sumitomo Pharma Co., Ltd. operates in the same pharmaceutical industry, producing drugs that could compete in the same therapeutic areas as Fuji Pharma.
Chugai Pharmaceutical
4519.TSE
Mkt Cap6.03T
Chugai Pharmaceutical Co., Ltd. is known for its biopharmaceuticals and research-driven products, competing in innovation and market share with Fuji Pharma.
Eisai
4523.TSE
Mkt Cap1.69T
Eisai Co., Ltd. competes in the pharmaceutical sector, focusing on neurology and oncology, areas that could overlap with Fuji Pharma's product lines.
Shionogi &.
4507.TSE
Mkt Cap2.12T
Shionogi & Co., Ltd. focuses on infectious diseases and CNS, presenting competition in research and development of new pharmaceuticals.
Kyowa Kirin.
4151.TSE
Mkt Cap1.75T
Kyowa Kirin Co., Ltd. specializes in biopharmaceuticals, competing in the same innovative drug market as Fuji Pharma.
OtsukaLtd.
4578.TSE
Mkt Cap2.43T
Otsuka Holdings Co., Ltd. offers a diverse range of pharmaceutical products, potentially competing across several of Fuji Pharma's key areas.
Takeda Pharmaceutical
4502.TSE
Mkt Cap6.05T
Takeda Pharmaceutical Company Limited operates globally, offering a wide range of pharmaceutical products that compete with Fuji Pharma's offerings.
Daiichi Sankyo.
4568.TSE
Mkt Cap8.21T
Daiichi Sankyo Company, Limited focuses on innovative pharmaceuticals, directly competing with Fuji Pharma in the development and marketing of new drugs.
Nippon Shinyaku.
4516.TSE
Mkt Cap517.95B
Nippon Shinyaku Co., Ltd. competes in the pharmaceutical industry, focusing on specialty and niche markets that may overlap with Fuji Pharma's strategic interests.

About

Fuji Pharma Co., Ltd. is a pharmaceutical company that operates globally, focusing on the complete spectrum of drug development, from initial research and discovery through manufacturing and commercialization. Its comprehensive product line includes various medical solutions such as injectable medications, oral therapeutics, topical treatments, and a range of diagnostic tools. Beyond its core pharmaceutical offerings, Fuji Pharma also specializes in women's healthcare products, advanced in vitro diagnostic technologies, and acute medical intervention solutions. The company further contributes by disseminating valuable pharmaceutical and general health information. Founded in 1965, Fuji Pharma Co., Ltd. has its corporate headquarters located in Tokyo, Japan.
Show more...
CEO
Shuhei Morita
Employees
1760
Country
Japan
ISIN
JP3816200004
WKN
000938283

Listings

0 Comments

Share your thoughts

FAQ

What is Fuji Pharma. stock price today?
The current price of FUP.STU is €9.70 EUR — it has increased by +1.04% in the past 24 hours. Watch Fuji Pharma. stock price performance more closely on the chart.
What is Fuji Pharma. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Fuji Pharma. stocks are traded under the ticker FUP.STU.
What is Fuji Pharma. market cap?
Today Fuji Pharma. has the market capitalization of 257.45M
When is the next Fuji Pharma. earnings date?
Fuji Pharma. is going to release the next earnings report on November 05, 2026.
What were Fuji Pharma. earnings last quarter?
FUP.STU earnings for the last quarter are 0.23 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Fuji Pharma. revenue for the last year?
Fuji Pharma. revenue for the last year amounts to 161.67M EUR.
What is Fuji Pharma. net income for the last year?
FUP.STU net income for the last year is 3.88M EUR.
How many employees does Fuji Pharma. have?
As of September 07, 2026, the company has 1,760 employees.
In which sector is Fuji Pharma. located?
Fuji Pharma. operates in the Health & Wellness sector.
When did Fuji Pharma. complete a stock split?
The last stock split for Fuji Pharma. was on June 27, 2018 with a ratio of 2:1.
Where is Fuji Pharma. headquartered?
Fuji Pharma. is headquartered in Tokyo, Japan.